Carson Wealth (CWM LLC)’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11K | Buy |
7,545
+1,072
| +17% | +$1.56K | ﹤0.01% | 4221 |
|
2025
Q1 | $10K | Buy |
6,473
+5,463
| +541% | +$8.44K | ﹤0.01% | 4084 |
|
2024
Q4 | $1K | Sell |
1,010
-2,193
| -68% | -$2.17K | ﹤0.01% | 4652 |
|
2024
Q3 | $6K | Buy |
3,203
+3,101
| +3,040% | +$5.81K | ﹤0.01% | 3981 |
|
2024
Q2 | $1K | Buy |
102
+11
| +12% | +$108 | ﹤0.01% | 4303 |
|
2024
Q1 | $1K | Sell |
91
-86
| -49% | -$945 | ﹤0.01% | 4068 |
|
2023
Q4 | $1K | Buy |
177
+77
| +77% | +$435 | ﹤0.01% | 3889 |
|
2023
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 3917 |
|
2023
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 3896 |
|
2023
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 3763 |
|
2022
Q4 | $1K | Sell |
100
-1,522
| -94% | -$15.2K | ﹤0.01% | 3682 |
|
2022
Q3 | $12K | Hold |
1,622
| – | – | ﹤0.01% | 2545 |
|
2022
Q2 | $8K | Hold |
1,622
| – | – | ﹤0.01% | 2678 |
|
2022
Q1 | $8K | Hold |
1,622
| – | – | ﹤0.01% | 2582 |
|
2021
Q4 | $10K | Buy |
+1,622
| New | +$10K | ﹤0.01% | 2330 |
|
2021
Q2 | $12K | Hold |
1,498
| – | – | ﹤0.01% | 2006 |
|
2021
Q1 | $12K | Hold |
1,498
| – | – | ﹤0.01% | 2006 |
|
2020
Q4 | $12K | Hold |
1,498
| – | – | ﹤0.01% | 2006 |
|
2020
Q3 | $12K | Buy |
1,498
+1,448
| +2,896% | +$11.6K | ﹤0.01% | 2006 |
|
2020
Q2 | $12K | Hold |
50
| – | – | ﹤0.01% | 2006 |
|
2020
Q1 | $12K | Hold |
50
| – | – | ﹤0.01% | 2006 |
|
2019
Q4 | $12K | Hold |
50
| – | – | ﹤0.01% | 2006 |
|
2019
Q3 | $12K | Hold |
50
| – | – | ﹤0.01% | 2006 |
|
2019
Q2 | $12K | Hold |
50
| – | – | ﹤0.01% | 2006 |
|
2019
Q1 | $12K | Buy |
+50
| New | +$12K | ﹤0.01% | 2006 |
|